Medicus Pharma Ltd.
Last updated September 27, 2026
Organization details
- Legal name
- Medicus Pharma Ltd.
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Ontario, Canada
- Headquarters city
- W. Conshohocken
- Headquarters state / province
- Pennsylvania
- Headquarters country
- Canada
- Fiscal year end
- December
- Ticker symbol
- MDCX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001997296
- EIN
- 98-1778211
Board of directors
-
Ajay Raju · DirectorSince 2025
-
Barry Fishman · DirectorSince 2024
-
Cathy McMorris Rodgers · DirectorSince 2025
-
Frank W. Lavelle · DirectorSince 2024
-
Larry Kaiser · DirectorSince 2024
-
Patrick J. Mahaffy · DirectorSince 2025
-
Raza Bokhari · Director · Chief Executive OfficerSince 2024
-
Robert J. Ciaruffoli · DirectorSince 2024
-
Sara R. May · DirectorSince 2024
-
William Ashton · DirectorSince 2024
Chief executives
Raza Bokhari
· Chief Executive Officer
Since December 2024
Director election results
Annual meeting of June 3, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
97.0%
-
97.7%
-
97.7%
-
97.8%
-
97.8%
-
97.8%
-
97.8%
-
97.8%
-
97.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 4, 2026 | Raza Bokhari Director, Officer (Chief Executive Officer) | Grant or award | +2,941,176 | $0.17 | $501,471 |
| Sep 4, 2026 | Bonner Carolyn F. Officer (President and CFO) | Grant or award | +1,470,588 | $0.17 | $250,735 |
| Sep 4, 2026 | Brennan Edward J. Officer (Chief Scientific Officer) | Grant or award | +588,235 | $0.17 | $100,294 |
| Sep 4, 2026 | Mehmud Faisal Officer (Chief Medical Officer) | Grant or award | +1,470,588 | $0.17 | $250,735 |
| Sep 4, 2026 | Smith Andrew Alasdair Officer (Chief Operating Officer) | Grant or award | +735,294 | $0.17 | $125,368 |
| Aug 13, 2025 | Quinlan James P. Officer (Chief Financial Officer) | Option exercise | +125,000 | $0.81 | $101,250 |
| Aug 13, 2025 | Quinlan James P. Officer (Chief Financial Officer) | Option exercise | +20,000 | $2.75 | $55,000 |
| May 20, 2025 | Melani Kenneth R. 10% owner | Open-market sale | −75,000 | $7.72 | $579,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.